78 results
S-1
EX-10.34
AGRX
Agile Therapeutics Inc
IPO registration
14 Jun 24
4:40pm
8-K
EX-10.1
AGRX
Agile Therapeutics Inc
23 Feb 24
Agile Therapeutics Announces Exercise of Warrants for $4.8 Million Gross Proceeds
4:30pm
8-K
EX-10.1
AGRX
Agile Therapeutics Inc
15 Feb 24
Net Revenue for Full Year 2023 Expected to be in the Range of $20 to $21 Million, an Increase of 84% to 93% Compared to Full Year 2022
4:45pm
S-1
EX-10.19
AGRX
Agile Therapeutics Inc
IPO registration
11 Dec 23
5:30pm
8-K
EX-10.1
fkeqwmc72ysakbeqcbg
4 Dec 23
Entry into a Material Definitive Agreement
8:00am
8-K
EX-10.1
glqz8jc48ze9cgzib
28 Sep 23
Entry into a Material Definitive Agreement
4:50pm
8-K/A
EX-10.1
ts0 4us19k2dzqi0cv
22 Aug 23
Departure of Directors or Certain Officers
8:30am
8-K
EX-10.2
hquwd9fulrx08p5k4
25 May 23
Agile Therapeutics Announces Pricing of $7.5 Million Public Offering
5:25pm
8-K
EX-10.1
pkquu9e2es q8y
25 May 23
Agile Therapeutics Announces Pricing of $7.5 Million Public Offering
5:25pm
8-K
EX-10.1
p8bvdszmdeo2cf6fq
8 Jul 22
Agile Therapeutics Announces Pricing of
5:16pm